Hanall Biopharma Co.,Ltd (009420.KS) KSC

42,500.00

-200(-0.47%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap1.96T
Enterprise Value1.95T
P/E Ratio916.59
PEG Ratio249.35
Price/Sales Ratio14
Price/Book Ratio13.43
Enterprise/Revenue13.93
Enterprise/EBITDA76.85

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue138.94B
Revenue/Share3,091.8
Gross Profit73.31B
EBITDA3.35B
Net Income-1.8B
Diluted EPS-35.59

Balance Sheet

Total Cash11.93B
Total Cash/Share239.53
Total Debt1.35B
Total Debt/Equity0.01
Current Ratio2.01
Book Value Per Share3,164.05

Price History

52-Week Change24.63
52-Week High57,100
52-Week Low24,000
Moving Average 50 Days42,929
Moving Average 200 Days32,201.5

Statistics

Average Volume948,473
Shares Outstanding50.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor263:250
Last Split DateMay 24, 2006